CONTACT US
Home > Browse by topic > Drug Discovery

Drug Discovery Expert Witnesses

Drug discovery disputes arise because the earliest stages of pharmaceutical research create the assets on which later commercial value depends. Patent litigation over compound, genus, and method-of-treatment claims frequently turns on what medicinal chemists and biologists knew, predicted, or could reasonably have pursued at the time of invention. Research collaborations, licensing agreements, and acquisitions generate their own conflicts when parties disagree about inventorship, the ownership of leads identified during a partnership, or whether a counterparty used commercially reasonable efforts to advance a program. Trade secret claims involving screening data, structure-activity relationships, and target validation work raise similarly contested questions about what was truly proprietary.

A drug discovery expert helps counsel reconstruct the scientific landscape and test each side's account of how a program actually progressed. In patent matters, that often means analyzing lead identification and optimization from the perspective of a person of ordinary skill, assessing whether the prior art provided a reason to select a particular compound, and evaluating enablement and written description for broad genus or functional claims. In contract, earnout, and trade secret disputes, the expert can review laboratory notebooks, assay data, and portfolio decisions to determine whether a program's trajectory reflected sound scientific judgment, misappropriated information, or a counterparty's failure to perform. That analysis anchors liability and gives damages experts a defensible view of the program's probability of success.

Opinions on drug discovery carry weight when they come from scientists who have made real go and no-go decisions on research programs. Round Table Group can identify medicinal chemists, pharmacologists, and translational scientists whose careers include organizations such as Pfizer, Merck, Genentech, and the National Institutes of Health, along with faculty who lead academic discovery laboratories. Experts with those backgrounds understand how targets are validated, how leads are optimized, and how portfolio decisions are actually made inside pharmaceutical companies, which makes their testimony grounded rather than theoretical. We've completed more than 75,000 expert searches for litigators and can match the therapeutic area and stage of research your case involves. Let us help you find the right expert for your drug discovery matter by calling us at (202) 908-4500.


Kinds of Cases We Work On

Round Table Group helps our clients find a wide variety of Drug Discovery expert witnesses for cases like:


Here are a few of our favorite Drug Discovery Expert Witnesses:

I have 40 years of experience and specialize in the field of biotechnology with specific knowledge in the areas of diagnostics, biopharmaceuticals and medical devices. I have published on such topics as toxicology and marketing. I have testified on point-of-care diagnostics, biopharmaceuticals and toxicology.

 

I have 35 years of experience, and specialize in the field of chemotherapy.

 

I have 50 years of experience, and specialize in the field of pharmaceuticals, drug Discovery, pharmacology, medicinal chemistry and biotechnology. I am the author of more than 100 scientific papers, patents and books. I am also a Patent Agent registered to practice before the United States Patent and Trademark Office.

 

I have 25 years of experience, and specialize in the field of molecular pharmacology with specific knowledge in the areas of cancer, assay development and drug development. I have published on such topics as structural biology, cancer and nerve gas agents.

 

I have 15 years of experience, and specialize in the field of drug discovery with specific knowledge in the areas of antimicrobial drug discovery, antiviral drug discovery, and biochemistry and medicinal chemistry. I have published on such topics as novel membrane targeted antibiotics, enzymology and biochemistry of purine biosynthesis, and combinatorial library design and synthesis.

 

Your Case Deserves The Best Drug Discovery Expert Witnesses

Registered icon

The right expert witnesses and consulting experts can make your case. That’s why we have spent so many hours over the past quarter century making sure our clients have just the right expert team — whether one expert or many, early-stage advice or expert reports and testimony. Across over 50,000 expert search assignments, we have honed a unique, customized approach to identifying, analyzing and connecting with expert talent so you can focus on winning your case.

I have 28 years of experience, and specialize in the field of biochemistry with specific knowledge in the areas of structural biology, drug discovery and bacterial toxins. I have published on such topics as drug discovery to prevent MRSA, structure and function of a bacterial adhesin in plaque bacteri and mechanism of action of vasopressin antagonists. For most of my career I was engaged in basic research. In recent years my focus has shifted to applied science in the area of drug discovery and design. I want to make a difference. This has been very gratifying for me.

 

I have 40 years of experience and specialize in the field of organic chemistry with specific knowledge in the areas of synthetic organic, bioanalytic and pharmaceutical chemistry. I have published on such topics as natural products synthesis, synthetic methodology and bioorganic chemistry. I have testified on drug discovery, drug development, chirality, stereochemistry, medicinal chemistry, and spectroscopic and physical characterization.

 

I have 25 years of experience and specialize in the field of CNS drug discovery, with specific knowledge of G protein-coupled receptors and brain disorders.

 

I have 30 years of experience, and specialize in the field of pharmaceuticals with specific knowledge in the areas of biotechnology, technology strategy and genomics. I have published on such topics as drug discovery, diabetes and ribonucleic acid (RNA) interference.

 

I have 10 years of experience and specialize in the field of medicinal chemistry, with specific knowledge of steroid hormone action, breast cancer therapy and drug discovery. I have published on such topics as estrogen signaling, novel antiestrogens and drug conjugated polymers.

 

I have 20 years of experience, and specialize in the field of immunology with specific knowledge in the areas of drug discovery, drug development and oncology. I have published on such topics as T cell development, non-profit drug discovery and cancer drugs.

 

I have 30 years of experience and specialize in the field of pharmacology, with specific knowledge of pharmaceuticals, drug toxicity and environmental toxicology. I have published on such topics as drug development, drug mechanism of action and drug toxicity. I have testified on pesticide poisoning.

 

I have 34 years of experience and specialize in the field of medicinal chemistry, with specific knowledge of process chemistry, drug discovery and organic chemistry. I have published on such topics as medicine synthesis, organic synthesis and structure-function.

 

I have 25 years of experience and specialize in the field of pharmaceutical discovery, with specific knowledge of anti-infectives, biotechnology and entrepreneurship. I have published on such topics as drug discovery, biotechnology and molecular genetics.

 

I have 12 years of experience, and specialize in the field of drug discovery with specific knowledge in the areas of antibiotics, antivirals and structure-based techniques. I have published on such topics as RNA as a drug target, discovery of antibiotics and antivirals (HCV). I have testified 10 times on topics such as antibiotics and targets, HCV inhibitors and RNA targets.

 

I have 30 years of experience, and specialize in the field of drug discovery and development with specific knowledge in the areas of ion channel drug discovery and development, ion channel safety concerns and ion channel intellectual property. I have published on such topics as specific ion channel drug discovery efforts, ion channel screening and counter-screening and cardiovascular, diabetes and pain therapeutic areas. I have helped commercialize two ion channel drugs and I still have drug candidates in clinical development. My group helped pioneer modern ion channel drug discovery.

 

I have 15 years of experience, and specialize in the field of drug discovery and medicinal chemistry with specific knowledge in the areas of cancer, antibacterials and neurodegeneration. I have published on such topics as novel anti-cancer drugs, novel antibacterial agents and novel neuroprotective compounds.

 

I have 25 years of experience, and specialize in the field of pharmaceuticals and chemicals with specific knowledge in the areas of drug discovery and development and chemicals. I have published on such topics as evalation of process feasibility and examination of project proposals.

 

I have 25 years of experience, and specialize in the field of pharmacology with specific knowledge in the areas of fibromyalgia, channelopathies and potassium channel modulation. I have published on such topics as rational drug design, fibromyalgia and potassium channels as drug targets. Recognition of my expertise in fibromyalgia has led to invitation to act as an advisor to the UK parliamentary system and to national and international charitable organizations.

 

I have 27 years of experience, and specialize in the field of chemistry with specific knowledge in the areas of organic chemistry, materials chemistry and surface chemistry. I have published on such topics as organic synthesis, antiinfective drug discovery and surface chemistry. Although an academic, I have interacted strongly with industry in the course of my career, culminating in the creation of a spin-out company for the commercialisation of some of our research.

 

I have 14 years of experience, and specialize in the field of drug discovery with specific knowledge in the areas of pharmacology, research and development, and immunology. I have published on such topics as basic research in inflammatory diseases, biochemistry, and immunology.

 

I have 24 years of experience and specialize in the field of drug discovery, with specific knowledge of medicinal chemistry, drug discovery technology and business leadership. I have published on such topics as anti-hypertensive drugs, HDL cholesterol lowering drugs and drug discovery.

 

I have 21 years of experience, and specialize in the field of structural biology with specific knowledge in the areas of protein structure, signaling and peroxidases. I have published on such topics as signal transduction, protein three-dimensional structures and enzyme mechanisms.

 

I have 25 years of experience, and specialize in the field of neurodegeneration with specific knowledge in the areas of cell biology, biochemistry and drug discovery. I have published on such topics as cellular transport processes, disease mechanisms, metals in the brain and cholesterol in the brain.

 

I have 10 years of experience, and specialize in the field of chemical biology with specific knowledge in the areas of protein kinases, protein tyrosine phosphatases and beta lactamases.

 

I have 40 years of experience and specialize in the field of biochemistry with specific knowledge in the areas of drug discovery, rational drug design and enzymology. I have published on such topics as biochemistry, drug discovery and organic synthesis. I have testified on textbook disputes.

 

I have 30 years of experience, and specialize in the field of biomedical mass spectrometry with specific knowledge in the areas of cancer chemoprevention, drug metabolism and natural products. I have published on such topics as safety and efficacy of botanical dietary supplements, natural product drug discovery and cancer chemoprevention. I have testified on high-throughput screening for drug discovery, dietary supplements and pharmaceutical analysis.

 

I have 22 years of experience, and specialize in the field of drug discovery with specific knowledge in the areas of stereoselective synthesis, organic chemistry and pharmaceutical. I have published on such topics as organic chemistry, medicinal chemistry and oncology.

 

Put Our Drug Discovery Expert Network to Work for You

Registered icon

Our huge network of experts – eminent university professors and practitioners who have achieved renown as thought leaders in their fields – combined with unparalleled research capabilities puts the experts you need at your disposal when and where you need them.

If you’re a litigator or general counsel, we want to put this network to work for you and your clients. Let us know how we can help by calling us at (202) 908-4500 or filling out the form on this page. We’re so confident you’ll love what we do that unless you retain an expert we present there’s no charge!

Questions Attorneys Ask About Drug Discovery Expert Witnesses:

A drug discovery expert is warranted when the merits depend on how a compound or target was identified, what the field understood at a given time, or whether research obligations were performed. Engaging the expert early in Hatch-Waxman, collaboration, or trade secret matters helps counsel frame invalidity and infringement theories and identify the laboratory records that will matter most.

GET STARTED FINDING THE RIGHT EXPERT WITNESS

Spend your time working with your experts, not searching for them! We're here to de-stress the process of having a great expert witness team so that it’s easy to have the right experts every time. We'll conduct a quick but thorough search and deliver a roster of top candidates for you to review. There's no charge for the custom search — you pay only the hourly rate if you retain one of our experts.

  • This field is for validation purposes and should be left unchanged.

Or call 202-908-4500 or email us.

Drug Discovery Workshops

A few of the courses and workshops led by our Drug Discovery experts:

  • Complex Chemistry Made Simple: Challenges in Drug Discovery
  • Microfluidics and Flow Chemistry in Drug Discovery